相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Advances in Medicinal Chemistry and Pharmaceutical Technology-Strategies for Drug Delivery to the Brain
Nunzio Denora et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: Evidence for multiple steps and lateral association coupled to conformational conversion
Santosh Kumar et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
A century of Alzheimer's disease
Michel Goedert et al.
SCIENCE (2006)
Pyrroloquinoline quinone (PQQ) prevents fibril formation of α-synuclein
Masaki Kobayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
A century-old debate on protein aggregation and neurodegeneration enters the clinic
Peter T. Lansbury et al.
NATURE (2006)
Single chain Fv antibodies against the 25-35 Aβ fragment inhibit aggregation and toxicity of Aβ42
Andleeb Zameer et al.
BIOCHEMISTRY (2006)
Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway:: Implications in the aggregation mechanism of β-amyloid peptide
Dongxiang Liu et al.
BIOCHEMISTRY (2006)
Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat
Yonghua Zhang et al.
BRAIN RESEARCH (2006)
Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism
Y Porat et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
3D structure of Alzheimer's amyloid-β(1-42) fibrils
T Lührs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42
R Liu et al.
NEUROBIOLOGY OF DISEASE (2005)
Inhibition of α-synuclein fibrillization by dopamine analogs via reaction with the amino groups of α-synuclein
HT Li et al.
FEBS JOURNAL (2005)
In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features
IV Baskakov et al.
BIOCHEMISTRY (2005)
In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrPSc
OV Bocharova et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Molecular pathways to neurodegeneration
E Bossy-Wetzel et al.
NATURE MEDICINE (2004)
The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils
M Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hsp70 reduces α-synuclein aggregation and toxicity
J Klucken et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Differential cytotoxicity of human wild type and mutant α-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine
CEH Moussa et al.
BIOCHEMISTRY (2004)
Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro
K Ono et al.
EXPERIMENTAL NEUROLOGY (2004)
A new redox-cofactor vitamin for mammals
T Kasahara et al.
NATURE (2003)
In vitro cell-free conversion of bacterial recombinant PrP to Prpres as a model for conversion
L Kirby et al.
JOURNAL OF GENERAL VIROLOGY (2003)
An autocatalytic reaction, as a model for the kinetics of the aggregation of beta-amyloid
R Sabate et al.
BIOPOLYMERS (2003)
Cytotoxicity tests for high-throughput drug discovery
K Slater
CURRENT OPINION IN BIOTECHNOLOGY (2001)
分享论文
